Blog

How a long-known biomarker backs BioNTech’s antibody for pancreatic cancer

September 12, 2019 The team found that blocking CA19-9 could serve as a therapeutic strategy to prevent the progression from chronic pancreatitis to pancreatic cancer.  The findings were just published in the journal Science, but they have already been translated into an antibody drug acquired by BioNTech called MVT-5873. The CA19-9 antibody is already in … Read more

FDA sets novel device approval record for 2018, outlines new criteria for 510(k) clearances

September 05, 2019 In 2018, the FDA greenlit 106 new devices — including premarket approvals and panel-track supplements; de novo and breakthrough 510(k) clearances; and humanitarian device exemptions — beating out 2017’s 40-year record of 98 devices.  Some of these include the world’s smallest mechanical heart valve, developed by Abbott and St. Jude Medical for … Read more

U.K. calls for globally organized incentives for antibiotic R&D

September 03, 2019 In recent years, the U.K. has tried to establish itself at the forefront of global efforts to address the problem of antimicrobial resistance (AMR) through activities including an earlier five-year strategy and the commissioning of an independent review.  Now, the U.K. has set out its hopes for the next five (5) and … Read more

FDA Works to Improve Voluntary Recall Processes

August 29, 2019 FDA issued draft guidance at the end of April on voluntary recalls’ initiation process under 21 CFR part 7 subpart C. “We know that in order for a recall to be effective and timely, it’s crucial that companies be prepared in advance to take all necessary steps for when a recall is … Read more

FDA clears first medical device treatment for childhood ADHD

August 27, 2019 The prescription-only treatment — NeuroSigma’s Monarch external trigeminal nerve stimulation system — is designed for children who are currently not taking any medications.  About the size of a cellphone, the device delivers a mild electrical pulse to a wired patch placed on the patient’s forehead while sleeping.  By stimulating the branches of … Read more

After tragic Notre Dame fire, Sanofi pledges €10M to fix the cherished cathedral

August 20, 2019 Sanofi committed the donation via Twitter in April.  In a statement, CEO Olivier Brandicourt said the cathedral had “survived for centuries” and Sanofi would help make sure that does not change.  The drugmaker “can be proud that our company is participating in its restoration for future generations,” he said. Sanofi joins many … Read more

Fed up with the blame game on insulin prices, lawmakers say enough is enough

August 15, 2019 Going forward, though, one thing will change, several lawmakers told the pharma and PBM executives. The “status quo is not going to continue,” Rep. Joe Kennedy said.  “It can’t.” That remains to be seen, but at a hearing, members of the House Committee on Energy and Commerce highlighted some of the reasons … Read more

Federal agencies charge 24 in $1.2B Medicare telemedicine fraud scheme

August 13, 2019 The scheme of illegal kickbacks and bribes could amount to one of the largest healthcare fraud cases ever seen by the FBI and the Department of Health and Human Services’ (DHHS) Inspector General’s Office, according to the agencies. Arrests were made Tuesday, April 9, 2019, and two (2) dozen people have been … Read more